Oliver-Gely v. HI DEVELOPMENT PR CORP.

472 F. Supp. 2d 140, 72 Fed. R. Serv. 277, 2007 U.S. Dist. LEXIS 5931, 2007 WL 196842
District Court, D. Puerto Rico·Decided January 11, 2007·No. Civil 04-1238 (GAG)·Published

Opinion

OPINION AND ORDER

GELPI, District Judge.

Siblings and girlfriend of hotel guest brought this negligence action against hotel and its insurance company, alleging that hotel guest died from a bacterial infection he contracted after falling in hotel bathroom and tearing his skin. Defendants filed a motion in limine to exclude the testimony of the Plaintiffs’ expert witness as to causation. After reviewing the pleadings and pertinent law, the court DENIES Defendants’ motion to exclude the testimony of Plaintiffs’ expert witness (Docket No. 46).

*142 I. Proposed Expert Testimony

On March 22, 2003, Ricardo Oliver and Valerie Ember checked into the Ponce Inn Hotel. Mr. Oliver, a paraplegic, was visiting Puerto Rico from Florida. The following morning, Mr. Oliver fell while taking a shower in his hotel bathroom when the chair he was sitting on allegedly broke. A week later, on March 29, 2003, Mr. Oliver died due to urinary tract infection and sepsis. Both conditions were caused by the bacteria Citrobacter freun-dii. 1

At issue in this case is whether Mr. Oliver’s bacterial infection came from a skin lesion he suffered after falling in his hotel bathroom or whether it came from a bladder infection. To establish that Mr. Oliver contracted the bacteria from the skin lesion, Plaintiffs propose to call Dr. Angel Roman-Franco, a pathologist, as an expert witness. Dr. Roman opines that the bacteria that killed Mr. Oliver entered his blood after he fell in his hotel bathroom and tore his skin. See Exhibit 3, p. 12, Docket No. 46. This opinion is based on the following premises. Mr. Oliver sustained a laceration in his right gluteus or buttock when he fell in his hotel bathroom. Id. at 1. Open injuries in the gluteus are especially susceptible to infection by Citrobacter bacteria. Id. at 2. Mr. Oliver was immuno-compromised because people with spinal cord injuries suffer from diminished immunity. Id. at 3. The absence of a normal immune system makes antibodies less available to assist in the destruction and removal of pathogens. Id. at 5.

II. Legal Standard

The admission of expert testimony is governed by Federal Rule of Evidence 702. Under Rule 702, a qualified expert witness may testify “in the form of an opinion, or otherwise, if (1) the testimony is based upon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case.” Fed. R.Evid. 702. This rule “imposes a gate-keeping function on the trial judge to ensure that an expert’s testimony ‘both rests on a reliable foundation and is relevant to the task at hand.’” United States v. Mooney, 315 F.3d 54, 62 (1st Cir.2002) (quoting Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579, 597, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993)).

Before performing a Daubert analysis in this case, the court heeds the First Circuit’s admonitions about applying Daubert at the pretrial stage. See Cortes-Irizarry v. Corporacion Insular De Seguros, 111 F.3d 184, 188 (1st Cir.1997). In Cortes, the First Circuit stated that “a trial setting normally will provide the best operating environment for the triage which Daubert demands.” Id. The Court noted that “given the complex factual inquiry required by Daubert, courts will be hard-pressed in all but the most clearcut cases to gauge the reliability of the expert proof on a truncated record.” Id. From this, the Court concluded that “at the junction where Daubert intersects with summary judgment practice, Daubert is accessible, but courts must *143 be cautious—except when defects are obvious on the face of a proffer—not to exclude debatable scientific evidence without affording the proponent of the evidence adequate opportunity to defend its admissibility.” Id.

III. Legal Analysis

Defendants have moved to exclude the testimony of Dr. Roman on the ground that there is no objective evidence to prove that Mr. Oliver suffered a laceration, that the skin tear in his buttock ever became infected, and that he was immuno-compro-mised. Additionally, Defendants argue that Dr. Roman’s testimony should be excluded because he used a flawed methodology to reach his conclusions. The court will now evaluate these claims.

In his report, Dr. Roman concluded that Mr. Oliver suffered a laceration when the chair he was sitting on allegedly broke. At his deposition, Dr. Roman stated that he based his conclusion on Mr. Oliver’s medical record. See Exhibit 2, p. 63, Docket No. 46. Because this record describes Mr. Oliver’s lesion as a skin tear, Defendants argue that Dr. Roman had no objective evidence from which to conclude that Mr. Oliver suffered a laceration. Defendants’ argument fails for several reasons. First, Dr. Roman stated in his deposition that a laceration is a type of skin tear. Id. at 60-61. Second, Dr. Roman also explained that a skin tear is the most likely lay-term used to describe a laceration. Id. at 64. Finally, Dr. Roman’s opinion does not hinge on whether Mr. Oliver’s lesion was a laceration as opposed to a skin tear. In his report, Dr. Roman used both terms to describe Mr. Oliver’s lesion. See Exhibit 3, p. 1, Docket No. 46. For these reasons, the court cannot conclude that Dr. Roman had no objective evidence from which to conclude that Mr. Oliver suffered a laceration.

Free access — add to your briefcase to read the full text and ask questions with AI

Oliver-Gely v. HI DEVELOPMENT PR CORP., 472 F. Supp. 2d 140, 72 Fed. R. Serv. 277, 2007 U.S. Dist. LEXIS 5931, 2007 WL 196842 (prd 2007).

472 F. Supp. 2d 140 (Oliver-Gely v. HI DEVELOPMENT PR CORP.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
United States v. Diaz
300 F.3d 66 (First Circuit, 2002)
United States v. Mooney
315 F.3d 54 (First Circuit, 2002)